AstraZeneca promotes AI use in disease detection

AstraZeneca’s A. Catalyst Network – a connected array of more than 20 hubs worldwide – has welcomed a new hub to its fold: The Africa Health Innovation Hub.

The hub – which was launched at the Daspoort Poli Clinic in Pretoria – drives the company’s commitment to healthcare equity and fostering partnerships with a range of stakeholders, including governments, healthcare societies, academia, healthcare providers and patient advocacy groups, to better improve patient outcomes.

More importantly, it highlights AstraZeneca’s key partnerships with Tricog Health in Kenya and Medsol AI Solutions in South Africa. To this end, AstraZeneca has partnered with Medsol AI Solutions in South Africa, to help promote the use of AI in the detection of disease through a state-of-the-art wi-fi ultrasound probe that can detect breast cancer in seconds.

At the launch of the Africa Health Innovation Hub, healthcare practitioners were able to demonstrate the use of the Melusi Breast AI device in a community clinic setting, which is one of the first points of contact for clinical breast examinations and breast-cancer screening for patients.

Read full article –